Novel technology and the development of pharmacogenetics within the pharmaceutical industry

Pharmacogenomics

Volumn 6, Issue 4, 2005, Pages 339-356

  Gibson, Neil ^a   Jawaid, Ansar ^a   March, Ruth ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Candidate gene; Diagnostics; Genetic data; Pharmacogenetics; Polymorphism discovery; Whole genome association

Indexed keywords

ALPHA 1 ANTITRYPSIN; CARDIOVASCULAR AGENT; CETUXIMAB; GROWTH HORMONE; IMATINIB; RETINOIC ACID; RETINOID; TRASTUZUMAB;

ALPHA 1 ANTITRYPSIN DEFICIENCY; CHRONIC MYELOID LEUKEMIA; COLORECTAL CANCER; COMPUTER PROGRAM; DATA ANALYSIS; DIAGNOSTIC PROCEDURE; DRUG APPROVAL; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; DRUG SCREENING; DRUG SYNTHESIS; GASTROINTESTINAL TUMOR; GENE LINKAGE DISEQUILIBRIUM; GENE TECHNOLOGY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INFORMATION PROCESSING; MISMATCH REPAIR; MUTATIONAL ANALYSIS; PHARMACOGENETICS; PRADER WILLI SYNDROME; PRESCRIPTION; REVIEW; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION;

ANIMALS; DRUG DESIGN; DRUG INDUSTRY; GENOTYPE; HUMANS; MUTATION; PHARMACOGENETICS;

EID: 21444441699     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/14622416.6.4.339     Document Type: Review

References (56)

1. March R: Pharmacogenomics: the genomics of drug response. Yeast 17(1), 16-21 (2000).
2. Spear BB, Heath-Chiozzi M, Huff J: Clinical application of pharmacogenetics. Trends Mol. Med. 7(5), 201-204 (2001).
3. Roses AD: Pharmacogenetics and drug development: the path to safer and more effective drugs. Nature Rev. Genet. 5(9), 645-656 (2004).
4. Anderson DC, Gomez-Mancilla B, Spear BB et al. Elements of informed consent for pharmacogenetic research; perspective of the pharmacogenetics working group. Pharmacogenomics J. 2(5), 284-292 (2002).
5. Lesko LJ, Salerno RA, Spear BB et al.: Pharmacogenetics and pharmacogenomics in drug development and regulatory decision making: report of the first FDA-PWG-PhRMA-DruSafe Workshop. J. Clin. Pharmacol. 43(4), 342-358 (2003).
6. Zondervan KT, Cardon LR: The complex interplay among factors that influence allelic association. Nature Rev. Genet. 5(2), 89-100 (2004).
7. Hartmer R, Storm N, Boecker S et al.: RNase T1 mediated base-specific cleavage and MALDI-TOF MS for high-throughput comparative sequence analysis. Nucleic Acids Res. 31(9), e47 (2003).
8. Qiu P, Shandilya H, D'Alessio JM, O'Connor K, Durocher J, Gerard GF: Mutation detection using Surveyor nuclease. Biotechniques 36(4), 702-707 (2004).
9. Fakhrai-Rad H, Zheng J, Willis TD et al.: SNP discovery in pooled samples with mismatch repair detection. Genome Res. 14(7), 1404-1412 (2004).
10. Hodgson DR, Foy CA, Partridge M, Pateromichelakis S, Gibson NJ: Development of a facile fluorescent assay for the detection of 80 mutations within the p53 gene. Mol. Med. 8(5), 227-237 (2002).
11. Clayton SJ, Scott FM, Walker J et al.: K-ras point mutation detection in lung cancer: comparison of two approaches to somatic mutation detection using ARMS allele-specific amplification. Clin. Chem. 46(12), 1929-1938 (2000).
12. Lilleberg SL, Durocher J, Sanders C, Walters K, Culver K: High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform. Ann. NY Acad. Sci. 1022, 250-256 (2004).
13. Pignatti PF: Trends in pharmacogenomics of drugs used in the treatment of asthma. Pharmacol. Res. 49(4), 343-349 (2004).
14. Glatt CE, Reus VI: Pharmacogenetics of monoamine transporters. Pharmacogenomics 4(5), 583-596 (2003).
15. Gu BJ, Zhang W, Worthington RA et al.: A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. J. Biol. Chem. 276(14), 11135-11142 (2001).
16. Kurland L, Liljedahl U, Karlsson J et al.: Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Am. J. Hypertens. 17(1), 8-13 (2004).
17. Hughes AR, Mosteller M, Bansal AT et al.; CNA30027 Study Team; CNA30032 Study Team: Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations. Pharmacogenomics 5(2), 203-211 (2004).
18. Wang WY, Barratt BJ, Clayton DG, Todd JA: Genome-wide association studies: theoretical and practical concerns. Nature Rev. Genet. 6(2), 109-118 (2005).
19. Risch NJ: Searching for genetic determinants in the new millennium. Nature 405, 847-856 (2000).
20. Deloukas P, Bentley D: The HapMap project and its application to genetic studies of drug response. Pharmacogenomics J. 4(2), 88-90 (2004).
21. Armstrong VW, Shipkova M, von Ahsen N, Oellerich M: Analytic aspects of monitoring therapy with thiopurine medications. Ther. Drug Monit. 26(2), 220-226 (2004).
22. Witchel HJ, Milnes JT, Mitcheson JS, Hancox JC: Troubleshooting problems with in vitro screening of drugs for QT interval prolongation using HERG K+ channels expressed in mammalian cell lines and Xenopus oocytes. J. Pharmacol. Toxicol. Methods 48(2), 65-80 (2002).
23. Hegi ME, Diserens AC, Godard S et al.: Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin. Cancer Res. 10(6), 1871-1874 (2004).
24. Kennedy GC, Matsuzaki H, Dong S et al.: Large-scale genotyping of complex DNA. Nature Biotechnol. 21(10), 1233-1237 (2003).
25. Johnson GC, Esposito L, Barratt BJ et al.: Haplotype tagging for the identification of common disease genes. Nature Genet. 29(2), 233-237 (2001).
26. Stram DO: Tag SNP selection for association studies. Genet. Epidemiol. 27(4), 365-374 (2004).
27. Phillips MS, Lawrence R, Sachidanandam R et al.: Chromosome-wide distribution of haplotype blocks and the role of recombination hot spots. Nature Genet. 33(3), 382-387 (2003).
28. Wang WY, Todd JA: The usefulness of different density SNP maps for disease association studies of common variants. Hum. Mol. Genet. 12(23), 3145-3149 (2003).
29. Halushka MK, Fan JB, Bentley K et al.: Patterns of single nucleotide polymorphisms in candidate genes for blood-pressure homeostasis. Nature Genet. 22(3), 239-247 (1999).
30. Cargill M, Altshuler D, Ireland J et al.: Characterization of single nucleotide polymorphisms in coding regions of human genes. Nature Genet. 22(3), 231-238 (1999). Errarum in: Nature Genet. 23(3), 373 (1999).
31. Stephens JC, Schneider JA, Tanguay DA et al.: Haplotype variation and linkage disequilibrium in 313 human genes. Science 293(5529), 489-493 (2001).
32. Botstein D, Risch N: Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet. 33(Suppl.), 228-237 (2003).
33. Hirschhorn JN, Daly MJ: Genome-wide association studies for common diseases and complex traits. Nature Rev. Genet. 6(2), 95-108 (2005).
34. Cambien F, Poirier O, Nicaud V et al.: Sequence diversity in 36 candidate genes for cardiovascular disorders. Am. J. Hum. Genet. 65(1), 183-191 (1999).
35. Jawaid A, Bader JS, Purcell S, Cherny SS, Sham P: Optimal selection strategies for QTL mapping using pooled DNA samples. Eur. J. Hum. Genet. 10(2), 125-132 (2002).
36. Sham P, Bader JS, Craig I, O'Donovan M, Owen M: DNA Pooling: a tool for large-scale association studies. Nature Rev. Genet. 3(11), 862-871 (2002).
37. Le Hellard S, Ballereau SJ, Visscher PM et al.: SNP genotyping on pooled DNAs: comparison of genotyping technologies and a semi automated method for data storage and analysis. Nucleic Acids Res. 30 (15), e74 (2002).
38. Bader JS, Sham P: Family-based association tests for quantitative traits using pooled DNA. Eur. J. Hum. Genet. 10(12), 870-878 (2002).
39. Gutman S: The role of Food and Drug Administration regulation of in vitro diagnostic devices - applications to genetics testing. Clin. Chem. 45(5), 746-749 (1999).
40. Sougakoff W, Rodrigue M, Truffot-Pernot C et al.: Use of a high-density DNA probe array for detecting mutations involved in rifampicin resistance in Mycobacterium tuberculosis. Clin. Microbiol. Infect. 10(4), 289-294 (2004).
41. Janne PA, Li C, Zhao X et al.: High-resolution single nucleotide polymorphism array and clustering analysis of loss of heterozygosity in human lung cancer cell lines. Oncogene 23(15), 2716-2726 (2004).
42. John S, Shephard N, Liu G et al.: Whole-genome scan, in a complex disease, using 11,245 single nucleotide polymorphisms: comparison with microsatellites. Am. J. Hum. Genet. 75(1), 54-64 (2004).
43. Zineh I, Gerhard T, Aquilante CL, Beitelshees AL, Beasley BN, Hartzema AG: Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs. Pharmacogenomics J. 4(6), 354-358 (2004).
44. Newton CR, Graham A, Heptinstall LE et al.: Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res. 17(7), 2503-2516 (1989).
45. Whitcombe D, Theaker J, Guy SP, Brown T, Little S: Detection of PCR products using self-probing amplicons and fluorescence. Nature Biotechnol. 17(8), 804-807 (1999).
46. Sosnowski R, Heller MJ, Tu E, Forster AH, Radtkey R: Active microelectronic array system for DNA hybridization, genotyping and pharmacogenomic applications. Psychiatr. Genet. 12(4), 181-192 (2002).
47. Gurtner C, Tu E, Jamshidi N et al.: Microelectronic array devices and techniques for electric field enhanced DNA hybridization in low-conductance buffers. Electrophoresis 23(10), 1543-1550 (2002).
48. March R, Cheeseman K, Doherty M: Pharmacogenetics - legal, ethical and regulatory considerations. Pharmacogenomics 2(4), 317-327 (2001).
49. Benjamini Y, Hochberg Y: Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. Roy. Statist. Soc. B 57, 289-300 (1995).
50. Storey JD: A direct approach to false discovery rates. J. Roy. Statist. Soc. B 64, 479-498 (2002)
51. Dudbridge F, Koeleman BP: Efficient computation of significance levels for multiple associations in large studies of correlated data, including genomewide association studies. Am. J. Hum. Genet. 75(3), 424-435 (2004).
52. Lernmark A, Ott J: Sometimes its hot, sometimes its not. Nature Genet. 19, 213-214 (1998).
53. Franke L, van Bakel H, Diosdado B, van Belzen M, Wapenaar M, Wijmenga C: TEAM: a tool for the integration of expression, and linkage and association maps. Eur. J. Hum. Genet. 12(8), 633-638 (2004).
54. Darvasi A: Genomics: Gene expression meets genetics. Nature 422(6929), 269-270 (2003).
55. Brem RB, Yvert G, Clinton R, Kruglyak L: Genetic dissection of transcriptional regulation in budding yeast. Science 296(5568), 752-755 (2002).
56. Jansen RC, Nap JP: Genetical genomics: the added value from segregation. Trends Genet. 17(7), 388-391 (2001).